Epstein Secrets

GHISLAINE MAXWELL EFTA01565365 EFTA01565366 For the Period 3/1/13 to 3/31/13 Account Summary Account Number Investment Account(s) GHISLAINE MAXWELL

GHISLAINE MAXWELL EFTA01565365 EFTA01565366 For the Period 3/1/13 to 3/31/13 Account Summary Account Number Investment Account(s) GHISLAINE MAXWELL GHISLAIN

GHISLAINE MAXWELL EFTA01565365 EFTA01565366 For the Period 3/1

Equity GENERAL MOTORS CO CV PFD B 37045V-20-9 GM PB JPMORGAN CHASE & CO 7.9% PFD STK APR 30 2049

70.81 10.18% Quantity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss Est. Annual Income Accrued Interest Yield EFTA01565394 GHISLAINE MAXWELL ACCT. For the Period 3/1/13 to 3/31/13 Price US Fixed Income A MI ST MUNI BOND AUTH ST CLEAN WTR REVOLVING FD 5% OCT 01 2026 DTD 11/02/2006 HELD BY

PER SHARE AS OF 03/13/13 (ID: UNILEVER N V TAX WITHHELD NETHERLANDS 15.00% AS OF 03/13/13 (ID: ASTRAZENECA PLC SPONS ADR @ 1.90 PER SHARE (ID: BHP LTD SPONS ADR @ 1.14 PER SHARE (ID: ROYAL DUTCH SHELL PLC ADR 0.86 PER SHARE AS OF 02/28/13 (ID: 930.000 930.000 350.000 320.000 300.000 1.90 1.14 0.86

GHISLAINE MAXWELL - OAP HID ACCT. For the Period 2/1/13 to 2/28/13 Trade Date Type Description Quantity Per Unit Amount Market Cost Sett 'e Date Settled Securitie

GHISLAINE MAXWELL - OAP HID ACCT. For the Period 2/1/13 to 2/28/1

GHISLAINE MAXWELL - OAP HID ACCT. For the Period 2/1/13 to 2/28/1

GHISLAINE MAXWELL - OAP HID ACCT. For the Period 2/1/13 t

BAYER A G SPONS ADR @ 99.52 19,904.00 BROKERAGE 8.00 ESI SECURITIES COMPANY (ID: 072730-30-2) 200.000 99.56 (19,912.00) • 1/29 2/1 Purchase BHP LTD SPONS ADR @ 78.4803 25,113/0 BROKERAGE 12.80 ESI SECURITIES COMPANY (ID: 088606-10-8) 320.000 78.52 (25,126.50) • 1/29 2/1 Purchase BOC HONG KONG HOLDI

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 4/1/13 to ♦/31/13 Trade Date Type Description Quantity Per Unit Amount Market Cost Sett 'e Date Settled Securitie

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 4/1/13 to ♦/31/13

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 4/1/13 to ♦/31/13

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 4/1/13 to

e BAYER A G SPONS ADR fa 101.72 9,663.40 BROKERAGE 3.80 ESI SECURITIES COMPANY (ID: 07273D-30-2) 95.000 101.76 (9,667.20) 4/22 4/25 Purchase BHP LTD SPONS ADR fa 63.825 1,914.75 BROKERAGE 1.20 ESI SECURITIES COMPANY (ID: 088606-10-8) 30.000 63.865 (1,915.95) 4172 4/25 Purchase BOC HONG KONG HOLDINGS

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 7/1/13 to 7/31/13 Trade Date Type Description Quantity Per Unit Amount Market Cost Sett 'e Date Settled Securitie

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 7/1/13 to 7/31/13

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 7/1/13 to 7/31/13

GHISLAINE MAXWELL-OAP HID ACCT. For the Period 7/1/13 to

to 7/31/13 Trade Date Type Description Quantity Per Unit Amount Market Cost Sett 'e Date Settled Securities Purchased 7/12 Purchase 7/17 BHP LTD SPONS ADR fa 60.9627 5,181.83 BROKERAGE 3.40 ESI SECURITIES COMPANY (ID: 088806-104) 85.000 61.003 (5,18523) 7/12 7/17 Purchase BOC HONG KONG HOLDINGS

GHISLAINE MAXWELL-OAP HID ACCT. For die Period 9/1/13 to 9/30/13 Portfolio Activity Detail INFLOWS & OUTFLOWS Settle Date Type Description Quantity Per Unit Amou

GHISLAINE MAXWELL-OAP HID ACCT. For die Period 9/1/13 to 9/30/13

GHISLAINE MAXWELL-OAP HID ACCT. For die Period 9/1/13 to 9/30/13

GHISLAINE MAXWELL-OAP HID ACCT. For die Period 9/1/13 to

3 496.99 9/19 Foreign Dividend MTN GROUP LTD SPONS ADR Q 0.368104 PER SHARE (ID: 62474M-10-8) 2,625.000 0.368 966.27 9/25 Foreign Dividend BHP LTD SPONS ADR @ 1.18 PER SHARE (ID: 088606-10-8) 435.000 1.18 513.30 9/26 Foreign Dividend ROYAL DUTCH SHELL PLC ADR 0.90 PER SHARE (ID: 780259-10-7) 405

CHISLAINE MAXWELL - OAP IHD ACCT. For the Period 9/1/13 to 9(30/13 Portfolio Activity Detail INFLOWS & OUTFLOWS Settle Date Type Description Quantity Per tine

19 FGN Tax Withheld MTN GROUP LTD SPONS ADR TAX WITHHELD SOUTH AFRICA 15.00% (ID: 62474M-10-8) 2,625.000 I.18 (144.94) 9/25 Foreign Dividend BHP LTD SPONS ADR (12 1.18 PER SHARE (ID: 088606-10-8) 435.000 513.30 J. P. Morgan Account Page 11 of 13 Consolidated Statement Page 53 Confidential Treatment